Association of a single nucleotide polymorphism in the C-reactive protein gene (-286) with susceptibility to Plasmodium falciparum malaria

Molecular Medicine

Volumn 16, Issue 1-2, 2010, Pages 27-33

  Giha, Hayder A ^a,b   Nasr, Amre ^c,d   Ekström, Mattias ^e   Israelsson, Elisabeth ^c   Arambepola, Gishanthi ^c   Arnot, David ^f   Theander, Thor G ^f   Troye Blomberg, Marita ^c   Berzins, Klavs ^c   Tornvall, Per ^e   Elghazali, Gehad ^b,g  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d AL NEELAIN UNIVERSITY   (Sudan)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g KING FAHAD MEDICAL CITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DIHYDROARTIMISININ; HEMOGLOBIN S; PYRIMETHAMINE; SULFADOXINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; C REACTIVE PROTEIN GENE; CHILD; CLINICAL EXAMINATION; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; MOUTH TEMPERATURE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BODY TEMPERATURE; C-REACTIVE PROTEIN; GENETIC PREDISPOSITION TO DISEASE; HEMOGLOBIN, SICKLE; HUMANS; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; STATISTICS, NONPARAMETRIC; SUDAN;

EID: 73949093593     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00136     Document Type: Article

References (33)

1. World Health Organization. World malaria report 2008 [Internet]. c2008. Geneva: World Health Organization; [cited 2009 Jan 20]. Available from: http://apps.who.int/malaria/wmr2008/.
2. Kwiatkowski DP. (2005) How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77:171-92.
3. Mackintosh CL, Beeson JG, Marsh K. (2004) Clinical features and pathogenesis of severe malaria. Trends Parasitol. 20:597-603.
4. Gabay C, Kushner I. (1999) Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:448-54.
5. Pepys MB, Hirschfield GM. (2003) C-reactive protein: a critical update. J. Clin. Invest. 111:1805-12.
6. Pepys MB, Baltz ML. (1983) Acute phase proteins with special references to C-reactive protein and related protein (pentaxins) and serum amyloid A protein. Adv. Immunol. 34:140-212.
7. Koj A. (1989) The role of interleukin-6 as the hepatocyte stimulating factor in the network of inflammatory cytokines. Ann. NY Acad. Sci. 557:1-8.
8. Du Clos TW, Mold C. (2004) C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol. Res. 30:261-77.
9. Bang R, et al. (2005) Analysis of binding sites in human C-reactive protein for FcγRI, FcγRIIA, and C1q by site-directed mutagenesis. J. Biol. Chem. 280:25095-102.
10. Stein MP, et al. (2000) C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J. Clin. Invest. 105:369-76.
11. Braga ÉM, et al. (2005) Polymorphism in the Fcγ receptor IIA and malaria morbidity. J. Mol. Genetic Med. 1:5-10.
12. Bisoendial RJ, Kastelein JJ, Stroes ES. (2007) C-reactive protein and atherogenesis: from fatty streak to clinical event. Atherosclerosis. 195:e10-8.
13. Imrie H, et al. (2007) Low prevalence of an acute phase response in asymptomatic children from a malaria-endemic area of Papua New Guinea. Am. J. Trop. Med. Hyg. 76:280-4
14. Gotschlich EC, Edelman GM. (1967) Binding properties and specificity of C-reactive protein. Proc. Natl. Acad. Sci. U. S. A. 57:706-12.
15. Volanakis JE, Kaplan MH. (1971) Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc. Soc. Exp. Biol. Med. 136:612-4.
16. Harpaz R, et al. (1992) Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. J. Clin. Invest. 90:515-23.
17. Hurt N, et al. (1994) Evaluation of C-reactive protein and haptoglobin as malaria episode markers in an area of high transmission in Africa. Trans. R. Soc. Trop. Med. Hyg. 88:182-6.
18. Hurt N, Smith T, Teuscher T, Tanner M. (1994) Do high levels of C-reactive protein in Tanzanian children indicate malaria morbidity? Clin. Diagn. Lab. Immunol. 1:437-44.
19. Kathiresan S, et al. (2006) Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation. 113:1415-23.
20. Kovacs A, et al. (2005) A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis. 178:193-8.
21. Morita A, et al. (2007) Genotyping of triallelic SNPs using TaqMan PCR. Mol. Cell. Probes. 21:171-6.
22. Israelsson E, et al. (2009) Marked differences in CRP genotype frequencies between the Fulani and sympatric ethnic groups in Africa. Mal J. 22;8:136.
23. Creasey A, et al. (2004) Eleven years of malaria surveillance in a Sudanese village highlights unexpected variation in individual disease susceptibility and outbreak severity. Parasitology. 129:263-71
24. A-Elbasit IE, Elbashir MI, Khalil IF, Alifrangis M, Giha HA. (2006) The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine for malaria treatment in rural Eastern Sudan: the interrelation between resistance, age and gametocytogenesis. Trop. Med. Int. Health. 11:604-12.
25. Giha HA, et al. (2000) The epidemiology of febrile malaria episodes in an area of unstable and seasonal transmission. Trans. R. Soc. Trop. Med. Hyg. 94:645-51.
26. World Health Organization. (1991) Basic malaria microscopy, part 1. Geneva: World Health Organization.
27. Fortin A, Stevenson MM, Gros P. (2002) Susceptibility to malaria as a complex trait: big pressure from a tiny creature. Hum. Mol. Genet. 11:2469-78.
28. Artavanis-Tsakonas K, Tongren JE, Riley EM. (2003) The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. Clin. Exp. Immunol. 133:145-52.
29. van den Broek NR, Letsky EA. (2000) Etiology of anemia in pregnancy in south Malawi. Am. J. Clin. Nutr. 72:247S-56S.
30. Naik P, Voller A. (1984) Serum C-reactive protein levels and falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 78:812-3.
31. Modiano D, et al. (2001) The lower susceptibility to Plasmodium falciparum malaria of Fulani of Burkina Faso (west Africa) is associated with low frequencies of classic malaria-resistance genes. Trans. R. Soc. Trop. Med. Hyg. 95:149-52.
32. Ashley-Koch A, Yang Q, Olney RS. (2000) Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. Am. J. Epidemiol. 151:839-45.
33. Dolo A, et al. (2005) Difference in susceptibility to malaria between two sympatric ethnic groups in Mali. Am. J. Trop. Med. Hyg. 72:243-8.